PMID: 9169805Mar 15, 1997Paper

Radiosurgery for skull base malignancies and nasopharyngeal carcinoma

International Journal of Radiation Oncology, Biology, Physics
A J CmelakD R Goffinet

Abstract

Patients with skull base lesions present a challenging management problem because of intractable symptoms and limited therapeutic options. In 1989 we began treating selected patients with skull base lesions using linac stereotactic radiosurgery. In this study the efficacy and toxicity of this therapeutic modality is investigated. Forty-seven patients with 59 malignant skull base lesions were treated with linac radiosurgery between 1989 and 1995. Eleven patients were treated for primary nasopharyngeal carcinoma using radiosurgery as a boost (7 Gy-16 Gy, median: 12 Gy) to the nasopharynx after a course of fractionated radiotherapy (64.8-70 Gy) without chemotherapy. Another 37 patients were treated for 48 skull base metastases or local recurrences from primary head and neck cancers. Eight of these patients had 12 locally recurrent nasopharyngeal carcinoma lesions occuring 6-96 months after standard radiotherapy, including one patient with nasopharyngeal carcinoma who developed a regional relapse after radiotherapy with a stereotactic boost. Lesion volumes by CT or MRI ranged from 0 to 51 cc (median: 8 cc). Radiation doses of 7.0 Gy-35.0 Gy (median: 20.0 Gy) were delivered to recurrent lesions, usually as a single fraction. All 11 ...Continue Reading

References

Jan 1, 1992·International Journal of Radiation Oncology, Biology, Physics·P E FeehanK Fu
Feb 1, 1989·International Journal of Radiation Oncology, Biology, Physics·W Z ChenK S Luo
May 1, 1985·Cancer·J M Brown
Jan 1, 1986·International Journal of Radiation Oncology, Biology, Physics·A J Gray
Apr 1, 1988·International Journal of Radiation Oncology, Biology, Physics·J R Castro, M M Reimers
Jul 1, 1987·International Journal of Radiation Oncology, Biology, Physics·C C Wang
Feb 1, 1985·International Journal of Radiation Oncology, Biology, Physics·D R GoffinetW E Fee
Aug 1, 1985·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Z PetrovichJ Jepson
Jan 1, 1983·Acta Radiologica. Oncology·J H YanX Z Gu
Dec 1, 1984·International Journal of Radiation Oncology, Biology, Physics·A M ChuB Jose
Aug 1, 1993·International Journal of Radiation Oncology, Biology, Physics·A W LeeJ H Ho
Feb 15, 1993·International Journal of Radiation Oncology, Biology, Physics·D ChoyP M Wu

❮ Previous
Next ❯

Citations

Aug 31, 2002·Head & Neck·Ping-Ching PaiChen-Nen Chang
Feb 14, 2003·Current Oncology Reports·Edward GardnerEhab Y Hanna
Mar 4, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·J T ChangJ H Hong
Jul 13, 2000·International Journal of Radiation Oncology, Biology, Physics·A M SyedN S Ramsinghani
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·Y C AhnS H Chang
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·T NishiokaK Ohmori
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·M A HuntS A Leibel
Aug 23, 2001·International Journal of Radiation Oncology, Biology, Physics·J XiaoY Miao
Feb 19, 2002·International Journal of Radiation Oncology, Biology, Physics·Peter C LevendagPeter J C M Nowak
Nov 7, 2002·International Journal of Radiation Oncology, Biology, Physics·Stephen C K LawWai-Hon Lau
Feb 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Sanford L MeeksWilliam A Friedman
Apr 16, 2003·International Journal of Radiation Oncology, Biology, Physics·Daniel T T ChuaLucullus H T Leung
Jun 28, 2003·International Journal of Radiation Oncology, Biology, Physics·Quynh-Thu LeDon R Goffinet
Feb 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Tai-Xiang LuE Brian Butler
Mar 15, 1997·International Journal of Radiation Oncology, Biology, Physics·J S Cooper
Aug 27, 1998·International Journal of Radiation Oncology, Biology, Physics·J M HwangT L Phillips
Nov 26, 1999·International Journal of Radiation Oncology, Biology, Physics·D J TateD R Goffinet
Oct 23, 1998·Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists·T D SolbergA A DeSalles
Feb 27, 2003·Critical Reviews in Oncology/hematology·Lisa LicitraRoberto Molinari
May 20, 1999·The Laryngoscope·N MitsuhashiH Niibe
Feb 9, 2012·International Journal of Surgical Oncology·Tamer AltayWilliam T Couldwell
Jan 21, 2006·Stereotactic and Functional Neurosurgery·Yoshimasa MoriJun Yoshida
Jul 15, 2006·Stereotactic and Functional Neurosurgery·Kyota OdaJun Yoshida
Apr 4, 2009·Journal of Hematology & Oncology·Nicholas D CoppaWalter C Jean
Sep 23, 2011·Neurosurgery·Roukoz B ChamounFranco DeMonte
Dec 3, 2009·Neurosurgical Focus·Minh Tam TruongScharukh Jalisi
Jun 23, 2015·Clinical Otolaryngology : Official Journal of ENT-UK ; Official Journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery·A D RapidisA Ferlito
Jan 22, 2013·Oral Oncology·Chwee Ming LimRobert L Ferris
Mar 31, 2009·International Journal of Radiation Oncology, Biology, Physics·Farzan SiddiquiSamuel Ryu
Jan 2, 2009·International Journal of Radiation Oncology, Biology, Physics·Kwang-Won RohYeon-Sil Kim
Jan 1, 2008·International Journal of Radiation Oncology, Biology, Physics·Wendy HaraQuynh-Thu Le
Apr 22, 2006·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter M L TeoAnthony T C Chan
Nov 27, 2010·Neurosurgery Clinics of North America·Roukoz B Chamoun, Franco DeMonte
Apr 13, 2005·Otolaryngologic Clinics of North America·Meisong DingDavid Raben
Nov 21, 2007·Expert Review of Anticancer Therapy·Wendy HaraIris C Gibbs
Jul 3, 2007·Optometry : Journal of the American Optometric Association·Eulogio BesadaBenjamin Bittner
Nov 16, 2004·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Peter M L TeoAnthony T C Chan
Sep 20, 2006·Technology in Cancer Research & Treatment·George VoynovJonas Johnson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved